HS

HighVista Strategies Portfolio holdings

AUM $388M
1-Year Est. Return 180.25%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+180.25%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$388M
AUM Growth
-$19.7M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
181
New
Increased
Reduced
Closed

Top Buys

1
+$6.38M
2
+$5.85M
3
+$4.05M
4
PHVS icon
Pharvaris
PHVS
+$3.91M
5
STOK icon
Stoke Therapeutics
STOK
+$3.47M

Top Sells

1
+$12.9M
2
+$12.6M
3
+$12.3M
4
SNDK
Sandisk
SNDK
+$8.63M
5
DBC icon
Invesco DB Commodity Index Tracking Fund
DBC
+$8.61M

Sector Composition

1 Healthcare 69.79%
2 Technology 6.85%
3 Industrials 5.94%
4 Financials 3.09%
5 Consumer Discretionary 2.49%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BABA icon
151
Alibaba
BABA
$318B
– –
-3,757
BAC icon
152
Bank of America
BAC
$363B
– –
-27,500
BEKE icon
153
KE Holdings
BEKE
$19.1B
– –
-11,400
CNM icon
154
Core & Main
CNM
$10.2B
– –
-27,900
COF icon
155
Capital One
COF
$122B
– –
-9,674
CRBP icon
156
Corbus Pharmaceuticals
CRBP
$148M
– –
-118,027
CRH icon
157
CRH
CRH
$75.9B
– –
-19,439
CSCO icon
158
Cisco
CSCO
$319B
– –
-21,800
CZR icon
159
Caesars Entertainment
CZR
$5.2B
– –
-43,000
DVAX
160
DELISTED
Dynavax Technologies
DVAX
– –
-192,849
ENTG icon
161
Entegris
ENTG
$19.6B
– –
-15,700
EOLS icon
162
Evolus
EOLS
$362M
– –
-226,025
FN icon
163
Fabrinet
FN
$20.2B
– –
-5,100
INBX icon
164
Inhibrx
INBX
$1.09B
– –
-7,626
JCI icon
165
Johnson Controls International
JCI
$85.7B
– –
-11,100
KROS icon
166
Keros Therapeutics
KROS
$420M
– –
-83,050
MLTX icon
167
MoonLake Immunotherapeutics
MLTX
$1.29B
– –
-19,059
MRUS
168
DELISTED
Merus
MRUS
– –
-133,321
NTRA icon
169
Natera
NTRA
$28.3B
– –
-6,580
PGR icon
170
Progressive
PGR
$124B
– –
-5,500
PWR icon
171
Quanta Services
PWR
$85B
– –
-5,200
ROIV icon
172
Roivant Sciences
ROIV
$21.1B
– –
-98,858
SRRK icon
173
Scholar Rock
SRRK
$4.84B
– –
-59,573
STX icon
174
Seagate
STX
$84B
– –
-6,898
TAL icon
175
TAL Education Group
TAL
$6.43B
– –
-19,600
4 5 6
7
8